The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I’ve investigated whether this is the case. When investing, your capital is ...

The study was published in Nature Communications. Image Credit: Takanori Harashima DNA-nanoparticle motors are minuscule artificial motors that use RNA and DNA structures to drive motion through ...

Scientists at deCODE genetics have unveiled a groundbreaking map of human DNA mixing during reproduction, offering insights into genetic diversity, health, and fertility. Credit: SciTechDaily.com ...

Comparison of that ancient DNA with modern human DNA showed that the two species had interbred and that people today still carry the genetic fingerprint of that intermixing. Since then ...

Lurie Children’s Hospital of Chicago, Chicago, Illinois, USA, and president and co-founder of DNA Bridge, Durham, North Carolina, USA. Conflicts in Ukraine, Gaza, Sudan, Syria and elsewhere have ...

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The company’s shares closed last Friday at p1,359. ...

After 48 years on death row, the results of Zeigler’s successful battle for DNA testing could mark a breakthrough. Tommy Zeigler, 79, pictured on Nov. 26, 2024, has said he is innocent of ...